Agree completely, though there are thousands to be tested, IMO there are less than 100 with any real shot as to working, less than 25 with real pedigrees that could be put into use within a year or more, and maybe 10 or so with a safety profile that C19 investigators are looking for of those 25 drugs meeting the requirements mentioned above.
Kind of like the Cy Young Award in Major League Baseball; every pitcher in the league has a shot prior to opening day but in reality everyone knows there are only 2 or 3 pitchers in each league that have a legitimate shot at winning the award.
One major weakness I have noted about most people and for the most part all corporation is that they tend to focus on their weaknesses and the competitors strength's to lull themselves into defensive positions when they are actually the 800# gorilla in the room and should start acting like they know it and the competition better darned well know it.
Somebody posted within the last 10 days or so a great post that listed all the strengths of B (about 10 or so) that fell PERFECTLY into what C19 investigators are looking for in a treatment/vaccine drug. How many drugs can say that? I will say 1 and that is Brilacidin.
True, we are small, underfunded, overlooked (or being hammered by BPs purposely to try and get us to sell out cheaply), and the company is constantly besmirched even by it's own shareholders (or those saying they are shareholders)but like King Arthur, we have the tool that will be able to put a very major dent into the C19 problem affecting the world currently.
I like our chances, they are not a longshot, they are extremely good.
Kind of the same thinking as Brooks Koepka heading into a major golf event, he says though there are 150 people teeing off there are only about 2 or 3 that even have a chance against him due to talent, history, mental toughness, etc.
Let's start thinking like Koepka, champions, as it won't be long until Brilacidin will come to the fore in testing.
News 
Market Data 
Discover 
